Home  »  Finance   »  Is Now A Good Time To Invest In vTv Therapeutics I...

Is Now A Good Time To Invest In vTv Therapeutics Inc. (NASDAQ: VTVT)?

vTv Therapeutics Inc. (NASDAQ:VTVT) shares, rose in value on Friday, 05/13/22, with the stock price up by 5.77% to the previous day’s close as strong demand from buyers drove the stock to $0.43.

Actively observing the price movement in the last trading, the stock closed the session at $0.40, falling within a range of $0.41 and $0.4399. The value of beta (5-year monthly) was -1.57. Referring to stock’s 52-week performance, its high was $2.88, and the low was $0.39. On the whole, VTVT has fluctuated by -38.24% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.


With the market capitalization of vTv Therapeutics Inc. currently standing at about $41.85 million, investors are eagerly awaiting this quarter’s results, scheduled for Aug 02, 2022 – Aug 08, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.07, which is expected to increase to $0 for fiscal year -$0.17 and then to about -$0.32 by fiscal year 2022. Data indicates that the EPS growth is expected to be 5.60% in 2022, while the next year’s EPS growth is forecast to be -88.20%.

Analysts have estimated the company’s revenue for the quarter at $1 million, with a low estimate of $1 million and a high estimate of $1 million. According to the average forecast, sales growth in current quarter could jump down -84.40%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2022, the company’s y-o-y revenues would reach $4.5 million, representing a decrease of -29.80% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that VTVT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of VTVT currently trading nearly -34.98% and -34.51% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 27.86, while the 7-day volatility ratio is showing 10.78% which for the 30-day chart, stands at 10.38%. Furthermore, vTv Therapeutics Inc. (VTVT)’s beta value is -1.41, and its average true range (ATR) is 0.06. The company’s stock has been forecasted to trade at an average price of $3.25 over the course of the next 52 weeks, with a low of $1.50 and a high of $5.00. Based on these price targets, the low is -248.84% off current price, whereas the price has to move -1062.79% to reach the yearly target high. Additionally, analysts’ median price of $3.25 is likely to be welcomed by investors because it represents a decrease of -655.81% from the current levels.

Data on historical trading for vTv Therapeutics Inc. (NASDAQ:VTVT) indicates that the trading volumes over the past 3 months, they’ve averaged 247.46K. According to company’s latest data on outstanding shares, there are 66.72 million shares outstanding.

Nearly 54.82% of vTv Therapeutics Inc.’s shares belong to company insiders and institutional investors own 9.80% of the company’s shares. The stock has fallen by -57.29% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VTVT stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts



Download Free eBook For


100% free. stop anytime no spam